Online citations, reference lists, and bibliographies.
← Back to Search

Fractional Flow Reserve-guided Percutaneous Coronary Intervention: Standing The Test Of Time

F. Zimmermann, L. X. V. Nunen
Published 2016 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Percutaneous coronary intervention (PCI) improves symptoms and prognosis in ischemia-inducing, functionally signifi cant, coronary lesions. Use of fractional fl ow reserve allows physicians to investigate the ischemia-inducing potential of a specifi c lesion and can be used to guide coronary revascularization, especially in multivessel coronary artery disease. Fractional fl ow reserve-guided PCI has been extensively investigated. Results show that deferral of stenting in non-signifi cant lesions is safe, whereas deferral of stenting in functionally signifi cant lesions worsens outcome. FFR-guided PCI improves outcome in multivessel disease over angiography-guided PCI. Until recently, there was little known about the long-term outcome of FFR-guided revascularization and its validity in acute coronary syndromes. This review aims to address the new evidence regarding long-term appropriateness of FFR-guided PCI, the need for hyperemia to evaluate functional severity, and the use of FFR in acute coronary syndromes.
This paper references
Cine-coronary arteriography.
F. Sones (1962)
Instantaneous Flow Response and Regional Distribution During Coronary Hyperemia as Measures of Coronary Flow Reserve
K. Gould (1974)
10.1161/01.CIR.49.4.703
Discrepancies Between Cineangiographic and Postmortem Findings in Patients with Coronary Artery Disease and Recent Myocardial Revascularization
C. Grondin (1974)
10.1001/JAMA.1978.03290190031023
Coronary angiogram interpretation. Interobserver variability.
J. E. Galbraith (1978)
10.1056/NEJM197907123010201
Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty.
A. Gruentzig (1979)
10.1161/01.CIR.82.5.1595
Effects of adenosine on human coronary arterial circulation.
R. Wilson (1990)
10.1161/01.CIR.87.4.1354
Experimental Basis of Determining Maximum Coronary, Myocardial, and Collateral Blood Flow by Pressure Measurements for Assessing Functional Stenosis Severity Before and After Percutaneous Transluminal Coronary Angioplasty
N. Pijls (1993)
10.1161/01.CIR.89.3.1013
Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography.
B. de Bruyne (1994)
Coronary fl ow reserve calculated from pressure measurements in humans. Validation with positron emission tomography. Circulation 1994;89:1013–22
B De Bruyne (1994)
Coronary fl ow reserve calculated from pressure measurements in humans . Validation with positron emission tomography
B DeBruyne (1994)
10.1161/01.CIR.92.8.2333
Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease.
E. Topol (1995)
10.1056/NEJM199606273342604
Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses.
N. Pijls (1996)
10.1161/01.CIR.94.8.1842
Simultaneous coronary pressure and flow velocity measurements in humans. Feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index, and fractional flow reserve.
B. de Bruyne (1996)
10.1161/01.CIR.97.6.535
Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction.
R. Hachamovitch (1998)
10.1002/CCD.1234
Incremental doses of intracoronary adenosine for the assessment of coronary velocity reserve for clinical decision making
E. Di Segni (2001)
10.1161/01.CIR.103.24.2928
Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis A Randomized Trial
G. J. W. Bech (2001)
Incremental doses of intracoro - nary adenosine for the assessment of coronary velocity reserve for clinical decision making
E DiSegni (2001)
10.1161/01.CIR.0000061950.24940.88
Intracoronary and Intravenous Adenosine 5′-Triphosphate, Adenosine, Papaverine, and Contrast Medium to Assess Fractional Flow Reserve in Humans
B. de Bruyne (2003)
Intracoronary and intravenous adenosine 5 -triphosphate, adenosine, papaverine, and contrast medium to assess fractional fl ow reserve in humans. Circulation 2003;107:1877–83
B De Bruyne (2003)
10.1016/J.JACC.2007.01.087
Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study.
N. Pijls (2007)
10.1161/CIRCULATIONAHA.107.743963
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy
L. Shaw (2008)
10.1016/S0084-3873(09)79441-6
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy
B. Gersh (2009)
10.1056/NEJMoa0807611
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention.
Pim A. L. Tonino (2009)
10.1016/S0145-4145(09)79503-6
Frequency of Stress Testing to Document Ischemia Prior to Elective Percutaneous Coronary Intervention
B. Gersh (2009)
Update on FFR-Guided PCI 232 et al. Fractional fl ow reserve versus angiography for guiding percutaneous coronary intervention
PA Tonino (2009)
10.1016/j.jcin.2010.08.025
Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction.
A. Ntalianis (2010)
10.1016/j.jcin.2011.07.011
Clinical utility of regadenoson for assessing fractional flow reserve.
Pradeep K. Nair (2011)
10.1016/J.YCAR.2011.01.097
Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation
B. Gersh (2011)
10.1016/j.jacc.2011.11.003
Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study.
S. Sen (2012)
10.1016/j.jacc.2012.09.065
VERIFY (VERification of Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Coronary Artery Stenosis Severity in EverydaY Practice): a multicenter study in consecutive patients.
C. Berry (2013)
10.1093/eurheartj/ehs436
Functional assessment of coronary stenoses: can we live without it?
N. Pijls (2013)
10.4244/EIJV8I10A180
Comparison of intravenous adenosine and intravenous regadenoson for the measurement of pressure-derived coronary fractional flow reserve.
P. Arumugham (2013)
10.1056/NEJMoa1408758
Fractional flow reserve-guided PCI for stable coronary artery disease.
B. de Bruyne (2014)
10.1002/ccd.25055
Use of regadenoson for measurement of fractional flow reserve
Aditya Prasad (2014)
10.1016/j.jacc.2013.09.060
Multicenter core laboratory comparison of the instantaneous wave-free ratio and resting Pd/Pa with fractional flow reserve: the RESOLVE study.
Allen Jeremias (2014)
10.1016/j.jacc.2014.07.973
Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes.
N. Johnson (2014)
10.1161/CIRCINTERVENTIONS.113.000978
Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain?: The RIPCORD Study
N. Curzen (2014)
Fractional fl ow reserveguided PCI for stable coronary artery disease
B De Bruyne (2014)
10.4244/EIJY14M08_10
Single bolus intravenous regadenoson injection versus central venous infusion of adenosine for maximum coronary hyperaemia in fractional flow reserve measurement.
L. V. van Nunen (2015)
10.1016/S0140-6736(15)60648-1
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial
T. Engstrom (2015)
10.1093/eurheartj/ehu338
Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS–NSTEMI randomized trial
J. Layland (2015)
10.1016/S0140-6736(15)00057-4
Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial
L. V. Nunen (2015)
10.1016/j.carrev.2015.05.011
Pooled comparison of regadenoson versus adenosine for measuring fractional flow reserve and coronary flow in the catheterization laboratory.
J. Stolker (2015)
10.1016/j.jcin.2015.04.028
Intracoronary Adenosine: Dose-Response Relationship With Hyperemia.
J. Adjedj (2015)
10.1016/j.jcin.2015.01.029
Prospective Assessment of the Diagnostic Accuracy of Instantaneous Wave-Free Ratio to Assess Coronary Stenosis Relevance: Results of ADVISE II International, Multicenter Study (ADenosine Vasodilator Independent Stenosis Evaluation II).
J. Escaned (2015)
10.1016/j.ahj.2015.06.024
Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease.
F. Zimmermann (2015)
10.1093/eurheartj/ehv452
Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial.
F. Zimmermann (2015)
Single bolus intravenous regadenoson injection versus central venous infusion of adenosine for maximum coronary hyperaemia in fractional fl ow reserve measurement. EuroIntervention 2015;22:905–13
LX van Nunen (2015)
The CONTRAST study: can contrast injection better approximate FFR compared to pure resting physiology? Presented at EuroPCR
NP Johnson (2015)
10.1016/j.jcin.2016.01.028
Invasive Assessment of the Coronary Microcirculation.
W. Fearon (2016)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar